Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

National Notifiable Infectious Diseases: Weekly Tables

TABLE I. Weekly cases of selected* infrequently reported notifiable diseases (<1,000 cases reported during the preceding year), excluding U.S. territories -- United States, week ending December 30, 2017 (WEEK 52) †
Disease Total cases reported for previous years
Current
week
Cum
2017
5-year
weekly
average§
2016 2015 2014 2013 2012 States reporting cases
during current week (Count)
Anthrax - - - - - - - -  
Arboviral diseases, neuroinvasive and nonneuroinvasive ¶,**:                  
Chikungunya virus disease - 107 5 247 896 NN NN NN  
Eastern equine encephalitis virus disease - 1 0 7 6 8 8 15  
Jamestown Canyon virus disease - 67 - 15 11 11 22 2  
La Crosse virus disease - 44 - 35 55 80 85 78  
Powassan virus disease - 30 - 22 7 8 12 7  
St. Louis encephalitis virus disease - 9 - 8 23 10 1 3  
Western equine encephalitis virus disease - - - - - - - -  
Botulism, total - 79 4 201 195 161 152 168  
foodborne - 5 0 31 37 15 4 27  
infant - 71 3 144 138 127 136 123  
other(wound & unspecified) - 3 0 26 20 19 12 18  
Brucellosis 1 109 2 127 126 92 99 114 MD (1 )
Chancroid - 8 0 7 11 - - 15  
Cholera - 4 0 15 5 5 14 17  
Cyclosporiasis ** - 1,091 2 535 645 388 784 123  
Diphtheria - - - - - 1 - 1  
Haemophilus influenzae,
invasive disease (age <5 yrs) ††:
                 
serotype b - 22 1 30 29 40 31 30  
nontypeable - 113 6 196 175 128 141 115  
non-b serotype - 138 2 159 135 266 233 263  
unknown serotype 5 237 5 187 167 39 34 37 NY (1 ), GA (1 ), FL (3 )
Hansen's disease ** - 51 2 78 89 88 81 82  
Hantavirus Infections **:                  
Hantavirus infection non-HPS - - 0 6 3 NN NN NN  
Hantavirus pulmonary syndrome (HPS) - 8 0 31 21 32 21 30  
Hemolytic uremic syndrome, post-diarrheal ** - 246 4 307 274 250 329 274  
Hepatitis B, perinatal virus infection §§ - 19 1 32 37 47 48 40  
Influenza-associated pediatric mortality **, ¶¶ 1 127 4 82 130 141 160 52 TN (1 )
Leptospirosis ** - 49 1 78 40 38 NN NN  
Listeriosis 1 731 14 786 768 769 735 727 NY (1 )
Measles *** - 122 5 85 188 667 187 55  
Meningococcal disease (Neisseria meningitidis) †††:                  
serogroup ACWY - 63 4 126 120 123 142 161  
serogroup B - 67 2 86 111 89 99 110  
other serogroup - 14 0 21 21 25 17 20  
unknown serogroup 2 186 5 142 120 196 298 260 OR (2 )
Novel influenza A virus infections §§§ - 67 0 23 7 3 21 313  
Plague - 1 - 4 16 10 4 4  
Poliomyelitis, paralytic - - - - - - 1 -  
Polio virus infection, nonparalytic ** - - - - - - - -  
Psittacosis ** - 3 0 12 4 8 6 2  
Q fever total **: - 129 3 164 156 168 170 135  
acute - 99 2 132 122 132 137 113  
chronic - 30 1 32 34 36 33 22  
Rabies, human - - - - 2 1 2 1  
SARS-CoV - - - - - - - -  
Smallpox - - - - - - - -  
Streptococcal toxic shock syndrome ** - 278 6 283 335 259 224 194  
Syphilis, congenital ¶¶¶ - 589 9 633 493 458 348 322  
Toxic shock syndrome (other than streptococcal) ** - 24 1 40 64 59 71 65  
Trichinellosis ** - 14 1 26 14 14 22 18  
Tularemia - 213 2 230 314 180 203 149  
Typhoid fever (caused by Salmonella typhi) - 288 8 376 367 349 338 354  
Vancomycin-intermediate Staphylococcus aureus ** - 89 3 108 183 212 248 134  
Vancomycin-resistant Staphylococcus aureus ** - - - - 3 - - 2  
Viral hemorrhagic Fevers ****:                  
Crimean-Congo hemorrhagic fever - - - - - NP NP NP  
Ebola hemorrhagic fever - - - - - 4 NP NP  
Guanarito hemorrhagic fever - - - - - NP NP NP  
Junin hemorrhagic fever - - - - - NP NP NP  
Lassa fever - - - - 1 1 NP NP  
Lujo virus - - - - - NP NP NP  
Machupo hemorrhagic fever - - - - - NP NP NP  
Marburg fever - - - - - NP NP NP  
Sabia-associated hemorrhagic fever - - - - - NP NP NP  
Yellow fever - - - - - - - -  
Zika virus disease, non-congenital †††† - 444 14 5,132 NN NN NN NN  
  • -: No reported cases N: Not reportable. NA: Not Available NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts.
  • * Case counts for reporting year 2017 are provisional and subject to change. Data for years 2012 through 2016 are finalized. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.
  • † This table does not include cases from the U.S. territories. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.
  • § Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. Additional information is available at https://wwwn.cdc.gov/nndss/document/5yearweeklyaverage.pdf.
  • ¶ Updated weekly reports from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
  • ** Not reportable in all reporting jurisdictions. Data from states where the condition is not reportable are excluded from this table, except for the arboviral diseases and influenza-associated pediatric mortality. Reporting exceptions are available at https://wwwn.cdc.gov/nndss/downloads.html.
  • †† Data for Haemophilus influenzae (all ages, all serotypes) are available in Table II.
  • §§ In 2016, the nationally notifiable condition 'Hepatitis B Perinatal Infection' was renamed to 'Perinatal Hepatitis B Virus Infection' and reflects updates in the 2016 CSTE position statement for Perinatal Hepatitis B Virus Infection.
  • ¶¶ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since October 1, 2017, thirteen influenza-associated pediatric death occurring during the 2017-18 season have been reported.
  • *** No measles cases were reported for the current week.
  • ††† Data for meningococcal disease (all serogroups) are available in Table II.
  • §§§ Novel influenza A virus infections are human infections with influenza A viruses that are different from currently circulating human seasonal influenza viruses. With the exception of one avian lineage influenza A (H7N2) virus, all novel influenza A virus infections reported to CDC since 2012 have been variant influenza viruses. Total case counts are provided by the Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD).
  • ¶¶¶ Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
  • **** Prior to 2015, CDC's National Notifiable Diseases Surveillance System (NNDSS) did not receive electronic data about incident cases of specific viral hemorrhagic fevers; instead data were collected in aggregate as "viral hemorrhagic fevers". Beginning in 2015, NNDSS has been updated to receive data for each of the viral hemorrhagic fevers listed below. In addition to the four cases of Ebola diagnosed in the United States to date in 2014, six residents of the United States have been medically evacuated to the United States for care after developing Ebola in West Africa. Ten of the 11 VHF cases reported for 2014 are confirmed as Ebola and one as Lassa fever.
  • †††† The Council of State and Territorial Epidemiologists approved position statement 16-ID-01 in June 2016, which modifies the previous case definition and naming convention from "Zika virus congenital infection" to "Zika virus disease, non-congenital".

TOP